本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phio Pharmaceuticals

0.9379
+0.01591.72%
成交量:6.38万
成交额:5.98万
市值:1,089.59万
市盈率:-0.70
高:0.9600
开:0.9600
低:0.9201
收:0.9220
52周最高:4.19
52周最低:0.8127
股本:1,161.73万
流通股本:1,154.81万
量比:0.92
换手率:0.55%
股息:- -
股息率:- -
每股收益(TTM):-1.3423
每股收益(LYR):-1.4535
净资产收益率:-113.71%
总资产收益率:-65.77%
市净率:0.86
市盈率(LYR):-0.65

数据加载中...

2022/04/29

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/22

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/10

重要事件披露

8-K - Current report
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/12

重要事件披露

8-K - Current report
2021/06/21

重要事件披露

8-K - Current report
2021/05/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/25

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals